Akoya Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Akoya Biosciences

08/05/2023 23:05

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 49 cents​​ per share for the quarter ended in March. The
mean expectation of eight analysts for the quarter was for a
loss of 48 cents per share.
    * Revenue rose 26.7% to $21.41 million from a year ago;
analysts
expected $20.32 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 49 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoya Biosciences Inc shares had fallen by 16.3% this
quarter and lost 28.4% so far this year.
    * The company reported a quarterly loss of $18.8 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $17.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 10:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.48          -0.49          Missed
 Dec. 31 2022      -0.43          -0.50          Missed
 Sep. 30 2022      -0.44          -0.47          Missed
 Jun. 30 2022      -0.37          -0.47          Missed